Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair

Abstract

We have hired and trained all necessary staff. We have received HRPO approval. We obtained IRB approval and continued review approval from JHU IRB and also IRB waivers from our primary recruitment sites (Union Memorial Hospital and University of Maryland Medical Center/ShockTrauma. The placebo purchase agreement and material transfer agreement have been agreed on and signed by JHU and Thera technologies responsible officials. We have enrolled and screened our first patient to the trial.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2018
Accession Number
AD1064653

Entities

People

  • Ala Elhelali
  • Jaimie T. Shores
  • Roberto Salvatori
  • Sami Tuffaha
  • Shivani Ahlawat
  • W. P. Lee

Organizations

  • Johns Hopkins University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Agreements
  • Availability
  • Biomedical Research
  • Classification
  • Contracts
  • Department Of Defense
  • Governments
  • Health Services
  • Hospitals
  • Information Operations
  • Instructions
  • Integrals
  • Inventions
  • Maryland
  • Materials
  • Monitoring
  • Peripheral Nervous System
  • Pituitary And Hypothalamic Hormones And Analogues
  • Security
  • Therapy
  • Universities

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Neuroscience